Discovery of a novel OGT inhibitor through high-throughput screening based on Homogeneous Time-Resolved Fluorescence (HTRF)
文献类型:期刊论文
作者 | Wu, Xinyu8,9; Wang, Mingchen5,8; Cao, Yu4,8; Xu, Ying3,8; Yang, Ziqun2,7; Ding, Yiluan1,7; Lu, Jing9; Zheng, Jie2,7; Luo, Cheng4,6,7,8![]() |
刊名 | BIOORGANIC CHEMISTRY
![]() |
出版日期 | 2023-10-01 |
卷号 | 139页码:12 |
关键词 | O-GlcNAcylation O-GlcNAc transferase High-throughput screening Inhibitor |
ISSN号 | 0045-2068 |
DOI | 10.1016/j.bioorg.2023.106726 |
通讯作者 | Zhao, Kehao(kehaozhao@gmail.com) ; Chen, Shijie(shijiechen@simm.ac.cn) |
英文摘要 | O-GlcNAcylation is a specific type of post-translational glycosylation modification, which is regulated by two enzymes, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). Aberrant overexpression of OGT is associated with the development of many solid tumors. In this study, we have developed and optimized a sensitive Ho-mogeneous Time-Resolved Fluorescence (HTRF) assay then identified a novel OGT inhibitor CDDO (also called Bardoxolone) through a high-throughput screening (HTS) based on HTRF assay. Further characterization sug-gested that CDDO is an effective OGT inhibitor with an IC50 value of 6.56 +/- 1.69 mu M. CPMG-NMR analysis confirmed that CDDO is a direct binder of OGT with a binding affinity (Kd) of approximately 1.7 mu M determined by the MST analysis. Moreover, HDX-MS analysis indicated that CDDO binds to the TPR domain and N-Terminal domain of OGT, which was further confirmed by the enzymatic competition experiments as the binding of CDDO to OGT was not affected by the catalytic site binding inhibitor OSMI-4. Our docking modeling analysis further predicted the possible interactions between CDDO and OGT, providing informative molecular basis for further optimization of the inhibitor in the future. Together, our results suggested CDDO is a new inhibitor of OGT with a distinct binding pocket from the reported OGT inhibitors. Our work paved a new direction for developing OGT inhibitors driven by novel mechanisms. |
WOS关键词 | O-GLCNAC TRANSFERASE ; BETA-N-ACETYLGLUCOSAMINE ; NUCLEOCYTOPLASMIC GLYCOSYLATION ; INSULIN-RESISTANCE ; GLCNACYLATION ; PROTEINS ; PATHWAY ; CANCER ; CELLS ; PHOSPHORYLATION |
资助项目 | National Key R & D Program of China[2022YFC3400500] ; National Natural Science Foundation of China[21877095] ; National Natural Science Foundation of China[91853205] ; Science and Technol- ogy Commission of Shanghai Municipality[21ZR1474700] ; Youth Innovation Promotion Association of CAS[2022279] ; Natural Science Foundation of Shandong Province[ZR2022MH291] |
WOS研究方向 | Biochemistry & Molecular Biology ; Chemistry |
语种 | 英语 |
WOS记录号 | WOS:001148470400001 |
出版者 | ACADEMIC PRESS INC ELSEVIER SCIENCE |
源URL | [http://119.78.100.183/handle/2S10ELR8/308918] ![]() |
专题 | 新药研究国家重点实验室 |
通讯作者 | Zhao, Kehao; Chen, Shijie |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Analyt Res Ctr Organ & Biol Mol, Shanghai 201203, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Immunol Dis, Shanghai 201203, Peoples R China 3.China Pharmaceut Univ, Nanjing 210009, Peoples R China 4.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210023, Jiangsu, Peoples R China 5.ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China 6.Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou 310024, Peoples R China 7.Univ Chinese Acad Sci, 19 Yuquan Rd, Beijing 100049, Peoples R China 8.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Ctr Chem Biol,State Key Lab Drug Res, Shanghai 201203, Peoples R China 9.Yantai Univ, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Minist Educ, Sch Pharm,Key Lab Mol Pharmacol & Drug Evaluat, Yantai 264005, Shandong, Peoples R China |
推荐引用方式 GB/T 7714 | Wu, Xinyu,Wang, Mingchen,Cao, Yu,et al. Discovery of a novel OGT inhibitor through high-throughput screening based on Homogeneous Time-Resolved Fluorescence (HTRF)[J]. BIOORGANIC CHEMISTRY,2023,139:12. |
APA | Wu, Xinyu.,Wang, Mingchen.,Cao, Yu.,Xu, Ying.,Yang, Ziqun.,...&Chen, Shijie.(2023).Discovery of a novel OGT inhibitor through high-throughput screening based on Homogeneous Time-Resolved Fluorescence (HTRF).BIOORGANIC CHEMISTRY,139,12. |
MLA | Wu, Xinyu,et al."Discovery of a novel OGT inhibitor through high-throughput screening based on Homogeneous Time-Resolved Fluorescence (HTRF)".BIOORGANIC CHEMISTRY 139(2023):12. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。